"A global collaboration to stop the epidemic" urges Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, in an article in Horizon Magazine.
Read moreNews Alert
The EU invests €30 million to map
new territory in health research
Brussels, 3 October 2011
BBC Radio 4 report on BLUEPRINT (4 minutes)
Q&A with BLUEPRINT’s Henk Stunnenberg on Epiexperts.com, social media site
The EU has invested €30 million to understand the epigenome - a link between genes, environment and health. BLUEPRINT, a new large-scale research project, will lead to targeted diagnostics, new treatments and preventive measures for specific diseases in individual patients; an approach known as 'personalised medicine'. BLUEPRINT, officially launched on 1 October, is the European cornerstone of an international research cooperation effort – the International Human Epigenome Consortium (IHEC), bringing together organisations and researchers from across the globe. The project upholds the EU's pledge to maximise open access to results of publicly-funded research, as teams from around the world will have a platform to openly share their results.
Read more: http://ec.europa.eu/research/index.cfm?pg=newsalert&lg=en&year=2011&na=na-031011
EURADIA is at the EASD, visit our stand in the Associations' Village. We invite you to take part in the consultation on the EPCRD!
Read moreAddress: Milnwood, 13 North Parade, Horsham, West Sussex, RH12 2BT, UK
Tel/Fax: 0044 (0)1403 276363